Inicio › Cáncer de pulmón › Nuevo México › Albuquerque
Ensayos clínicos de Cáncer de pulmón en Albuquerque, NM
14 estudios para Cáncer de pulmón buscan participantes en centros de Albuquerque y alrededores (a unos 30 millas). Abra un estudio para ver quién puede participar y cómo contactar con el equipo.
Texto oficial del estudio (inglés)
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
ReclutandoFase 3
- University of New Mexico Cancer Center, Albuquerque
Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer
ReclutandoFase 3
- University of New Mexico Cancer Center, Albuquerque
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
ReclutandoEstudio observacionalSe aceptan voluntarios sanos
- Lovelace Medical Center-Saint Joseph Square, Albuquerque
- University of New Mexico Cancer Center, Albuquerque
- Lovelace Women's Hospital, Albuquerque
- y 1 más
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
ReclutandoFase 3
- University of New Mexico Cancer Center, Albuquerque
A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)
ReclutandoFase 3
- University of New Mexico Cancer Center, Albuquerque
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
ReclutandoFase 3
- University of New Mexico Comprehensive Cancer Center, Albuquerque
Symbiotic-Lung-10: A Study to Learn About PF-08634404 Alone or in Combination in Early-stage or Locally Advanced NSCLC
ReclutandoFase 2
- New Mexico Oncology Hematology Consultants, Ltd, Albuquerque
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
ReclutandoFase 3
- University of New Mexico Comprehensive Cancer Center, Albuquerque
Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer
ReclutandoFase 3
- University of New Mexico Cancer Center, Albuquerque
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
ReclutandoFase 2
- University of New Mexico Cancer Center, Albuquerque
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
ReclutandoFase 2/3
- University of New Mexico Cancer Center, Albuquerque
VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma
ReclutandoFase 1/2
- Presbyterian Kaseman Hospital (site 208), Albuquerque
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
ReclutandoEstudio observacional
- Massive Bio SYNERGY-AI site, Albuquerque
Collection of Sputum and Labeling for Lung Cancer
ReclutandoEstudio observacionalSe aceptan voluntarios sanos
- Radiology Associates of Albuquerque, Albuquerque
Más información sobre Cáncer de pulmón en MedlinePlus
Ensayos de Cáncer de pulmón en otras ciudades
- Houston, TX78 estudios
- Boston, MA62 estudios
- New York City, NY60 estudios
- Los Angeles, CA45 estudios
- Arlington, VA41 estudios
- Washington, DC41 estudios
- Chicago, IL41 estudios
- Nashville, TN40 estudios
- Baltimore, MD40 estudios
- St. Louis, MO39 estudios
- Columbus, OH37 estudios
- Philadelphia, PA36 estudios
Otros estudios en Albuquerque
- Cáncer de pulmón de células no pequeñas18 estudios
- Cáncer de seno17 estudios
- Cáncer de ovario15 estudios
- Cáncer (todos los tipos)14 estudios
- Cáncer metastásico12 estudios
- Cáncer de endometrio12 estudios
- Diabetes tipo 211 estudios
- Enfermedad cardiovascular10 estudios
- Melanoma9 estudios
- Leucemia mielógena aguda9 estudios
- Cáncer de próstata9 estudios
- Enfermedad renal crónica8 estudios
De ClinicalTrials.gov, datos obtenidos el 6 oct 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.